Related Experiment Video
Updated: Aug 27, 2025
High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays
Published on: July 17, 2014
Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies
Kuang-Ting Ko1,2, Frank Lennartz1, David Mekhaiel3
1Department of Biochemistry, South Parks Road, University of Oxford, Oxford, OX1 3QU, UK.
Abstract:
An effective malaria vaccine remains a global health priority and vaccine immunogens which prevent transmission of the parasite will have important roles in multi-component vaccines. One of the most promising candidates for inclusion in a transmission-blocking malaria vaccine is the gamete surface protein Pfs48/45, which is essential for development of the parasite in the mosquito midgut. Indeed, antibodies which bind Pfs48/45 can prevent transmission if ingested with the parasite as part of the mosquito bloodmeal. Here we present the structure of full-length Pfs48/45, showing its three domains to form a dynamic, planar, triangular arrangement. We reveal where transmission-blocking and non-blocking antibodies bind on Pfs48/45. Finally, we demonstrate that antibodies which bind across this molecule can be transmission-blocking. These studies will guide the development of future Pfs48/45-based vaccine immunogens.
Insights
Developing a malaria vaccine is crucial. Antibodies targeting the Pfs48/45 protein, essential for parasite development in mosquitoes, can block malaria transmission, guiding future vaccine design.
Area of Science:
- Malariology
- Vaccinology
- Structural Biology
Background:
- An effective malaria vaccine is a global health priority.
- Transmission-blocking vaccines aim to prevent parasite development in mosquitoes.
- The Pfs48/45 gamete surface protein is a key target for transmission-blocking malaria vaccines.
Purpose of the Study:
- To determine the structure of the full-length Pfs48/45 protein.
- To map the binding sites of transmission-blocking and non-blocking antibodies on Pfs48/45.
- To guide the development of Pfs48/45-based malaria vaccine immunogens.
Main Methods:
- X-ray crystallography to determine the structure of full-length Pfs48/45.
- Antibody epitope mapping to identify binding sites.
- Functional assays to assess transmission-blocking activity of antibodies.
Main Results:
- The structure of full-length Pfs48/45 was determined, revealing a dynamic, planar, triangular arrangement of its three domains.
- Specific binding sites for transmission-blocking and non-blocking antibodies were identified.
- Antibodies binding across the Pfs48/45 molecule demonstrated transmission-blocking capabilities.
Conclusions:
- The determined structure provides insights into Pfs48/45 antigenicity.
- Understanding antibody binding sites is critical for designing effective transmission-blocking vaccine immunogens.
- This research supports the development of next-generation Pfs48/45-based malaria vaccines.
